Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin

Virology

Volumn 368, Issue 2, 2007, Pages 322-330

  Marzi, Andrea ^a,b   Mitchell, Daniel A ^c   Chaipan, Chawaree ^a,b   Fisch, Tanja ^a,b   Doms, Robert W ^d   Carrington, Mary ^e   Desrosiers, Ronald C ^f   Pöhlmann, Stefan ^a,b,g  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e SAIC FREDERICK INC   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antibody; Attachment; DC SIGN; MBL; Neutralization; SIV

Indexed keywords

CD209 ANTIGEN; GLYCAN DERIVATIVE; MANNOSE BINDING LECTIN; MONOCLONAL ANTIBODY 2G12; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; EBOLA VIRUS; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; CELL ADHESION MOLECULES; CELL LINE; GLYCOSYLATION; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; LECTINS, C-TYPE; MANNOSE-BINDING LECTIN; NEUTRALIZATION TESTS; POLYSACCHARIDES; RECEPTORS, CELL SURFACE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 35548993574     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.07.004     Document Type: Article

References (63)

1. Alvarez C.P., Lasala F., Carrillo J., Muniz O., Corbi A.L., and Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76 (2002) 6841-6844
2. Appelmelk B.J., Van D.I., van Vliet S.J., Vandenbroucke-Grauls C.M., Geijtenbeek T.B., and van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170 (2003) 1635-1639
3. Arrighi J.F., Pion M., Garcia E., Escola J.M., van Kooyk Y., Geijtenbeek T.B., and Piguet V. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200 (2004) 1279-1288
4. Arrighi J.F., Pion M., Wiznerowicz M., Geijtenbeek T.B., Garcia E., Abraham S., Leuba F., Dutoit V., Ducrey-Rundquist O., van Kooyk Y., Trono D., and Piguet V. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 78 (2004) 10848-10855
5. Baribaud F., Pöhlmann S., Sparwasser T., Kimata M.T., Choi Y.K., Haggarty B.S., Ahmad N., Macfarlan T., Edwards T.G., Leslie G.J., Arnason J., Reinhart T.A., Kimata J.T., Littman D.R., Hoxie J.A., and Doms R.W. Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J. Virol. 75 (2001) 10281-10289
6. Baribaud F., Pöhlmann S., Leslie G., Mortari F., and Doms R.W. Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J. Virol. 76 (2002) 9135-9142
7. Bashirova A.A., Geijtenbeek T.B., van Duijnhoven G.C., van Vliet S.J., Eilering J.B., Martin M.P., Wu L., Martin T.D., Viebig N., Knolle P.A., KewalRamani V.N., van Kooyk Y., and Carrington M. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J. Exp. Med. 193 (2001) 671-678
8. Bashirova A.A., Wu L., Cheng J., Martin T.D., Martin M.P., Benveniste R.E., Lifson J.D., KewalRamani V.N., Hughes A., and Carrington M. Novel member of the CD209 (DC-SIGN) gene family in primates. J. Virol. 77 (2003) 217-227
9. Binley J.M., Ngo-Abdalla S., Moore P., Bobardt M., Chatterji U., Gallay P., Burton D.R., Wilson I.A., Elder J.H., and de Parseval A. Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120. Retrovirology 3 (2006) 39
10. Boggiano C., Manel N., and Littman D.R. Dendritic cell-mediated trans-enhancement of HIV-1 infectivity is independent of DC-SIGN. J. Virol. 81 (2006) 2519-2523
11. Boukour S., Masse J.M., Benit L., Dubart-Kupperschmitt A., and Cramer E.M. Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes. J. Thromb. and Haemost. 4 (2006) 426-435
12. Buchacher A., Predl R., Strutzenberger K., Steinfellner W., Trkola A., Purtscher M., Gruber G., Tauer C., Steindl F., and Jungbauer A. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res. Hum. Retroviruses 10 (1994) 359-369
13. Burleigh L., Lozach P.Y., Schiffer C., Staropoli I., Pezo V., Porrot F., Canque B., Virelizier J.L., Arenzana-Seisdedos F., and Amara A. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol. 80 (2006) 2949-2957
14. Chaipan C., Soilleux E.J., Simpson P., Hofmann H., Gramberg T., Marzi A., Geier M., Stewart E.A., Eisemann J., Steinkasserer A., Suzuki-Inoue K., Fuller G.L., Pearce A.C., Watson S.P., Hoxie J.A., Baribaud F., and Pöhlmann S. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J. Virol. 80 (2006) 8951-8960
15. Curtis B.M., Scharnowske S., and Watson A.J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8356-8360
16. Dommett R.M., Klein N., and Turner M.W. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68 (2006) 193-209
17. Feinberg H., Guo Y., Mitchell D.A., Drickamer K., and Weis W.I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J. Biol. Chem. 280 (2005) 1327-1335
18. Furmonaviciene R., Ghaemmaghami A.M., Boyd S.E., Jones N.S., Bailey K., Willis A.C., Sewell H.F., Mitchell D.A., and Shakib F. The protease allergen Der p 1 cleaves cell surface DC-SIGN and DC-SIGNR: experimental analysis of in silico substrate identification and implications in allergic responses. Clin. Exp. Allergy 37 (2007) 231-242
19. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., and van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587-597
20. Geijtenbeek T.B., Koopman G., van Duijnhoven G.C., van Vliet S.J., van Schijndel A.C., Engering A., Heeney J.L., and van Kooyk Y. Rhesus macaque and chimpanzee DC-SIGN act as HIV/SIV gp120 trans-receptors, similar to human DC-SIGN. Immunol. Lett. 79 (2001) 101-107
21. Geijtenbeek T.B., van Vliet S.J., van Duijnhoven G.C., Figdor C.G., and van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1 receptor present in placenta that infects T cells in trans-A review. Placenta 22 Suppl. A (2001) S19-S23
22. Gummuluru S., Rogel M., Stamatatos L., and Emerman M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 77 (2003) 12865-12874
23. Guo Y., Feinberg H., Conroy E., Mitchell D.A., Alvarez R., Blixt O., Taylor M.E., Weis W.I., and Drickamer K. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 11 (2004) 591-598
24. Gurney K.B., Elliott J., Nassanian H., Song C., Soilleux E., McGowan I., Anton P.A., and Lee B. Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. J. Virol. 79 (2005) 5762-5773
25. He B., Qiao X., Klasse P.J., Chiu A., Chadburn A., Knowles D.M., Moore J.P., and Cerutti A. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 176 (2006) 3931-3941
26. Hong P.W., Flummerfelt K.B., de Parseval A., Gurney K., Elder J.H., and Lee B. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding. J. Virol. 76 (2002) 12855-12865
27. Hong P.W., Nguyen S., Young S., Su S.V., and Lee B. Optimal DC-SIGN binding to HIV-1 gp120 involves specific N-glycans within the 2G12 epitope. J. Virol. 81 (2007) 8325-8336
28. Hsu M., Harouse J.M., Gettie A., Buckner C., Blanchard J., and Cheng-Mayer C. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120. J. Virol. 77 (2003) 989-998
29. Hu Q., Frank I., Williams V., Santos J.J., Watts P., Griffin G.E., Moore J.P., Pope M., and Shattock R.J. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 199 (2004) 1065-1075
30. Johnson W.E., Sanford H., Schwall L., Burton D.R., Parren P.W., Robinson J.E., and Desrosiers R.C. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J. Virol. 77 (2003) 9993-10003
31. Kwon D.S., Gregorio G., Bitton N., Hendrickson W.A., and Littman D.R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16 (2002) 135-144
32. Lee B., Leslie G., Soilleux E., O'Doherty U., Baik S., Levroney E., Flummerfelt K., Swiggard W., Coleman N., Malim M., and Doms R.W. cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J. Virol. 75 (2001) 12028-12038
33. Lin G., Simmons G., Pöhlmann S., Baribaud F., Ni H., Leslie G.J., Haggarty B.S., Bates P., Weissman D., Hoxie J.A., and Doms R.W. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77 (2003) 1337-1346
34. Liu H., Hwangbo Y., Holte S., Lee J., Wang C., Kaupp N., Zhu H., Celum C., Corey L., McElrath M.J., and Zhu T. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. J. Infect. Dis. 190 (2004) 1055-1058
35. Liu H., Hladik F., Andrus T., Sakchalathorn P., Lentz G.M., Fialkow M.F., Corey L., McElrath M.J., and Zhu T. Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms. Eur. J. Hum. Genet. 13 (2005) 707-715
36. Liu H., Carrington M., Wang C., Holte S., Lee J., Greene B., Hladik F., Koelle D.M., Wald A., Kurosawa K., Rinaldo C.R., Celum C., Detels R., Corey L., McElrath M.J., and Zhu T. Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. J. Infect. Dis. 193 (2006) 698-702
37. Martin M.P., Lederman M.M., Hutcheson H.B., Goedert J.J., Nelson G.W., van Kooyk Y., Detels R., Buchbinder S., Hoots K., Vlahov D., O'Brien S.J., and Carrington M. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J. Virol. 78 (2004) 14053-14056
38. Marzi A., Akhavan A., Simmons G., Gramberg T., Hofmann H., Bates P., Lingappa V.R., and Pöhlmann S. The signal peptide of the Ebola virus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. J. Virol. 80 (2006) 6305-6317
39. Mitchell D.A., Fadden A.J., and Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276 (2001) 28939-28945
40. Mori K., Ringler D.J., and Desrosiers R.C. Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J. Virol. 67 (1993) 2807-2814
41. Moris A., Nobile C., Buseyne F., Porrot F., Abastado J.P., and Schwartz O. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103 (2004) 2648-2654
42. Moris A., Pajot A., Blanchet F., Guivel-Benhassine F., Salcedo M., and Schwartz O. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108 (2006) 1643-1651
43. Mummidi S., Catano G., Lam L., Hoefle A., Telles V., Begum K., Jimenez F., Ahuja S.S., and Ahuja S.K. Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts. J. Biol. Chem. 276 (2001) 33196-33212
44. Nobile C., Petit C., Moris A., Skrabal K., Abastado J.P., Mammano F., and Schwartz O. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 79 (2005) 5386-5399
45. Pikora C.A., Wittish C., and Desrosiers R.C. p6gag of human and simian immunodeficiency viruses is tolerant to small in-frame deletions downstream of the late domain. Virology 346 (2006) 479-489
46. Ploquin M.J., Diop O.M., Sol-Foulon N., Mortara L., Faye A., Soares M.A., Nerrienet E., Le Grand R., van Kooyk Y., Amara A., Schwartz O., Barre-Sinoussi F., and Muller-Trutwin M.C. DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm. J. Virol. 78 (2004) 798-810
47. Pöhlmann S., Stolte N., Munch J., Ten Haaft P., Heeney J.L., Stahl-Hennig C., and Kirchhoff F. Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. J. Infect. Dis. 180 (1999) 1494-1502
48. Pöhlmann S., Baribaud F., Lee B., Leslie G.J., Sanchez M.D., Hiebenthal-Millow K., Munch J., Kirchhoff F., and Doms R.W. DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J. Virol. 75 (2001) 4664-4672
49. Pöhlmann S., Soilleux E.J., Baribaud F., Leslie G.J., Morris L.S., Trowsdale J., Lee B., Coleman N., and Doms R.W. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 2670-2675
50. Rappocciolo G., Piazza P., Fuller C.L., Reinhart T.A., Watkins S.C., Rowe D.T., Jais M., Gupta P., and Rinaldo C.R. DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes. PLoS Pathog. 2 (2006) e70
51. Reitter J.N., and Desrosiers R.C. Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein. J. Virol. 72 (1998) 5399-5407
52. Reitter J.N., Means R.E., and Desrosiers R.C. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4 (1998) 679-684
53. Sanders R.W., Venturi M., Schiffner L., Kalyanaraman R., Katinger H., Lloyd K.O., Kwong P.D., and Moore J.P. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76 (2002) 7293-7305
54. Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F., Whitbeck J.C., Burke E., Buchmeier M.J., Soilleux E.J., Riley J.L., Doms R.W., Bates P., and Pöhlmann S. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305 (2003) 115-123
55. Trkola A., Kuster H., Rusert P., Joos B., Fischer M., Leemann C., Manrique A., Huber M., Rehr M., Oxenius A., Weber R., Stiegler G., Vcelar B., Katinger H., Aceto L., and Gunthard H.F. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat. Med. 11 (2005) 615-622
56. Turville S.G., Cameron P.U., Handley A., Lin G., Pöhlmann S., Doms R.W., and Cunningham A.L. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3 (2002) 975-983
57. Turville S.G., Santos J.J., Frank I., Cameron P.U., Wilkinson J., Miranda-Saksena M., Dable J., Stossel H., Romani N., Piatak Jr. M., Lifson J.D., Pope M., and Cunningham A.L. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103 (2004) 2170-2179
58. van Montfort T., Nabatov A.A., Geijtenbeek T.B., Pollakis G., and Paxton W.A. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. J. Immunol. 178 (2007) 3177-3185
59. Wu L., and KewalRamani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev., Immunol. 6 (2006) 859-868
60. Wu L., Bashirova A.A., Martin T.D., Villamide L., Mehlhop E., Chertov A.O., Unutmaz D., Pope M., Carrington M., and KewalRamani V.N. Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1568-1573
61. Wu L., Martin T.D., Vazeux R., Unutmaz D., and KewalRamani V.N. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J. Virol. 76 (2002) 5905-5914
62. Wu L., Martin T.D., Carrington M., and KewalRamani V.N. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 318 (2004) 17-23
63. Ying H., Ji X., Hart M.L., Gupta K., Saifuddin M., Zariffard M.R., and Spear G.T. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res. Hum. Retroviruses 20 (2004) 327-335